How to reduce your risks when providing botulinum toxin.
Buppert
Carolyn
C
D016907:Adverse Drug Reaction Reporting Systems; D001905:Botulinum Toxins / Q000009:adverse effects*; D002140:California; D017277:Drug Approval; D016903:Drug Monitoring; D006801:Humans; D016365:Liability, Legal; D008318:Malpractice / Q000331:legislation & jurisprudence*; D009465:Neuromuscular Agents / Q000009:adverse effects*; D010353:Patient Education as Topic; D012308:Risk Management / Q000458:organization & administration*; D014481:United States; D014486:United States Food and Drug Administration
D009465:Neuromuscular Agents; D001905:Botulinum Toxins